Real-time enrollment status for this alpha-1 antitrypsin deficiency clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 4:26 AM UTC
| NCT Number | NCT01851642 |
| Recruiting Status | Recruiting |
| Condition | Alpha-1 Antitrypsin Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 220 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Florida |
| Last Updated on CT.gov | November 6, 2025 (Nov 6, 2025) |
As of July 17, 2026: Clinical trial NCT01851642 is currently recruiting participants. This clinical trial study for alpha-1 antitrypsin deficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Florida. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01851642 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01851642 was last updated Nov 6, 2025 (November 6, 2025). HelloStudys verifies this status automatically.